No doubt last few weeks have been very disappointing. I have not...

No doubt last few weeks have been very disappointing. I have not sold a single share though.
My reasons for not selling [apart from the ones which I have already mentioned above]:

1. Chartwise:



A. it is approaching a strong support trendline - grey one in chart
B. price came down on very low volume - pretty much decreasing volume which is considered bullish.
C. only high volume down day [little red arrow] had a big reversal - red circle - which meant demand coming in.
D. since IPO, there have been only 3 big down days [black arrows] and all have meant exhaustion of supply and the price has rallied. which has meant there has been no dumping of shares on mkt by any of the big players.

2. Big players:
A. their biggest holder crescent capital partners didnt sold a single share since ipo and they have assured that they wont too:

https://cdn-api.markitdigital.com/a...access_token=83ff96335c2d45a094df02a206a39ff4

B. Ethical partners funds mgmt, another big player from IPO increased their holdings by 2m shares after IPO.

https://cdn-api.markitdigital.com/a...access_token=83ff96335c2d45a094df02a206a39ff4

C. Wilson Asset mgmt, Very reputed money manager. As per their report issued today, ACL is their main holdings in WAM Research & WAM Capital. Clearly they are also not selling otherwise they would have taken ACL off their report which acts as a brochure for new clients.

https://cdn-api.markitdigital.com/a...access_token=83ff96335c2d45a094df02a206a39ff4

D. Its one of the best picks by Bell potter:

https://www.livewiremarkets.com/wires/bell-potter-reporting-season-calendar-february-2022

and this is not because Bell Potter were the ones who did IPO; IPO was done by Goldman Sachs & BofA Securities. So that means Bell Potters acquired shares on mkt or via IPO.

E. Both Investors mutual ltd & Montgomery Investment mgmt consider this a buy:

https://www.livewiremarkets.com/wires/buy-hold-sell-5-stocks-in-an-upgrade-cycle-2021-10-14

3. Under-priced.

Although i've mentioned this before but if you read this article:

https://www.copyright link/street-t...p-to-1-7b-ipo-broker-research-20210416-p57jpw

Above is the broker research.

The brokers were valuing it close to 1.5b before the acquisition of medlabs and before the breakout half we just had.

All in all, some bad news will have to come for me to change my conviction in this holding. I wont be shaken out with these low volume moves.